Reference

Β·

Primary source

Thailand cannabis policy timeline (2018-2024)

Six major policy events

As of2018-2024Β·Sources3Β·Primary

Thailand's cannabis regulatory arc is anchored by six major policy events: 2018 β€” Narcotics Act Amendment legalises medical cannabis under FDA supervision; 2019 β€” Government Pharmaceutical Organization launches first state cultivation programme; 2021 β€” industrial hemp framework formalised with <0.2% THC threshold; June 2022 β€” cannabis delisted from Category 5 narcotics, effectively legalising adult use under a minimal permitting regime; 2023 β€” Bhumjaithai-led coalition campaigns to entrench legalisation, while incoming Pheu Thai government signals reversal; 2024 β€” re-classification of cannabis flower as a controlled medical herb with prescription requirement, ending the recreational-grey window. The policy oscillation has shaped a winners-and-losers split that favours medical, hemp, and CBD-export operators over recreational-storefront retail.

Figure in context

Thailand's cannabis regulatory arc is anchored by six major policy events: 2018 β€” Narcotics Act Amendment legalises medical cannabis under FDA supervision; 2019 β€” Government Pharmaceutical Organization launches first state cultivation programme; 2021 β€” industrial hemp framework formalised with <0.2% THC threshold; June 2022 β€” cannabis delisted from Category 5 narcotics, effectively legalising adult use under a minimal permitting regime; 2023 β€” Bhumjaithai-led coalition campaigns to entrench legalisation, while incoming Pheu Thai government signals reversal; 2024 β€” re-classification of cannabis flower as a controlled medical herb with prescription requirement, ending the recreational-grey window. The policy oscillation has shaped a winners-and-losers split that favours medical, hemp, and CBD-export operators over recreational-storefront retail.

Thailand's cannabis regulatory arc is anchored by six major policy events: 2018 β€” Narcotics Act Amendment legalises medical cannabis under FDA supervision; 2019 β€” Government Pharmaceutical Organization launches first state cultivation programme; 2021 β€” industrial hemp framework formalised with <0.2% THC threshold; June 2022 β€” cannabis delisted from Category 5 narcotics, effectively legalising adult use under a minimal permitting regime; 2023 β€” Bhumjaithai-led coalition campaigns to entrench legalisation, while incoming Pheu Thai government signals reversal; 2024 β€” re-classification of cannabis flower as a controlled medical herb with prescription requirement, ending the recreational-grey window. The policy oscillation has shaped a winners-and-losers split that favours medical, hemp, and CBD-export operators over recreational-storefront retail.

Time scope

2018-2024

Source basis

Primary source

Interpretation notes

What this tells you

Thailand's cannabis regulatory arc is anchored by six major policy events: 2018 β€” Narcotics Act Amendment legalises medical cannabis under FDA supervision; 2019 β€” Government Pharmaceutical Organization launches first state cultivation programme; 2021 β€” industrial hemp framework formalised with <0.2% THC threshold; June 2022 β€” cannabis delisted from Category 5 narcotics, effectively legalising adult use under a minimal permitting regime; 2023 β€” Bhumjaithai-led coalition campaigns to entrench legalisation, while incoming Pheu Thai government signals reversal; 2024 β€” re-classification of cannabis flower as a controlled medical herb with prescription requirement, ending the recreational-grey window. The policy oscillation has shaped a winners-and-losers split that favours medical, hemp, and CBD-export operators over recreational-storefront retail.

What not to do with it

The June 2022 delisting and 2024 re-classification bracket Thailand's recreational-grey window.

Related figures

Adjacent numbers that add context without drowning the value.

Report context

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

Thailand cannabis policy timeline (2018-2024) Β· Insight